SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001213900-17-012230
Filing Date
2017-11-16
Accepted
2017-11-16 16:30:59
Documents
1
Period of Report
2017-11-14

Document Format Files

Seq Description Document Type Size
1 OWNERSHIP DOCUMENT f4111417zarrabian_delmar.html 4  
1 OWNERSHIP DOCUMENT f4111417zarrabian_delmar.xml 4 5642
  Complete submission text file 0001213900-17-012230.txt   7088
Mailing Address P.O. BOX 675765 RANCHO SANTA FE CA 92067
Business Address
Zarrabian Saiid (Reporting) CIK: 0001495521 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-37823 | Film No.: 171208347

Mailing Address SUITE 720-999 WEST BROADWAY VANCOUVER A1 V5Z 1K5
Business Address SUITE 720-999 WEST BROADWAY VANCOUVER A1 V5Z 1K5 (604) 629-5989
DelMar Pharmaceuticals, Inc. (Issuer) CIK: 0001498382 (see all company filings)

IRS No.: 990360497 | State of Incorp.: NV | Fiscal Year End: 0630
SIC: 2834 Pharmaceutical Preparations
Assistant Director 1